News
5d
Zacks Investment Research on MSNWill New Drugs Enable BMY to Offset the Impact of Generic Competition?Bristol Myers BMY depends on newer drugs like Opdualag, Reblozyl and Breyanzi to stabilize its revenue base as its legacy ...
7mon
Verywell Health on MSNHeart Attack Medication for Prevention and Ongoing ManagementMedically reviewed by Jeffrey S. Lander, MD There are many types and combinations of drugs used to treat a myocardial infarction (MI), also known as a heart attack. These drugs can help prevent blood ...
Risk of clots, stroke from incorrect blood thinner dosing reduced using online dashboard ... The two most prescribed DOACs are rivaroxaban (brand name Xarelto) and apixaban (brand name Eliquis.) ...
More than two-thirds of people taking blood thinners take direct oral anticoagulants, or DOACs, which are under- or over-prescribed in up to one in eight patients. A new study finds that most ...
More than two-thirds of those people take a type of blood thinner called a direct oral anticoagulant. DOACs, such as rivaroxaban (brand name Xarelto) and apixaban (brand name Eliquis), are under ...
Blood thinners treat deep vein thrombosis (DVT), but they carry risks. Here’s what you need to know about these complications, and how to reduce possible side effects.
In a study of the three most commonly prescribed blood thinners, the oral anticoagulant rivaroxaban, known by the brand name Xarelto, was associated with a significantly higher risk of bleeding ...
Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast By Nick Paul Taylor Nov 20, 2023 5:00am Bayer Bristol Myers Squibb Pfizer Eliquis ...
The popular diabetes treatment Jardiance and the blood thinner Eliquis are among the first drugs that will be targeted for price negotiations in effort to cut Medicare costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results